BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36484512)

  • 21. Cyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesis.
    Ding J; Ning B; Gong W; Wen W; Wu K; Liang J; He G; Huang S; Sun W; Han T; Huang L; Cao G; Wu M; Xie W; Wang H
    J Biol Chem; 2009 Nov; 284(48):33311-9. PubMed ID: 19801633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses.
    Riedl A; Schlederer M; Pudelko K; Stadler M; Walter S; Unterleuthner D; Unger C; Kramer N; Hengstschläger M; Kenner L; Pfeiffer D; Krupitza G; Dolznig H
    J Cell Sci; 2017 Jan; 130(1):203-218. PubMed ID: 27663511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of kidney and protective effects of grape seed procyanidin B2 in db/db mice indicate MFG-E8 as a key molecule in the development of diabetic nephropathy.
    Zhang Z; Li BY; Li XL; Cheng M; Yu F; Lu WD; Cai Q; Wang JF; Zhou RH; Gao HQ; Shen L
    Biochim Biophys Acta; 2013 Jun; 1832(6):805-16. PubMed ID: 23474305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in milk fat globule-EGF factor 8 inhibits triple-negative breast cancer cell viability and migration.
    Yang Y; Li J; Song Q; Zhu K; Yu X; Tian Y; Zhang J
    Oncol Lett; 2019 Mar; 17(3):3457-3465. PubMed ID: 30867784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
    Lee JE; Lim MS; Park JH; Park CH; Koh HC
    Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of REG4 expression on chemoresistance of ovarian cancer.
    Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
    J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
    Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression levels and clinical significance of MFG-E8 and CD133 in epithelial ovarian cancer.
    Li N; Dai C; Yang Y; Wu X; Wang L; Wang P
    Gynecol Endocrinol; 2020 Sep; 36(9):803-807. PubMed ID: 31899997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
    Zhu H; Diao S; Lim V; Hu L; Hu J
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.
    Parrales A; López E; Lee-Rivera I; López-Colomé AM
    Cell Signal; 2013 Apr; 25(4):829-38. PubMed ID: 23291002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.
    Chu P; Xu L; Su H
    J Physiol Biochem; 2019 Jun; 75(2):163-171. PubMed ID: 30863948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment.
    Jinushi M; Nakazaki Y; Carrasco DR; Draganov D; Souders N; Johnson M; Mihm MC; Dranoff G
    Cancer Res; 2008 Nov; 68(21):8889-98. PubMed ID: 18974133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitidine Chloride Triggers Autophagy and Apoptosis of Ovarian Cancer Cells through Akt/mTOR Signaling Pathway.
    Lian C; Huang Y; Hu P; Cao Y; Zhang Z; Feng F; Zhang J
    Curr Pharm Des; 2023; 29(19):1524-1534. PubMed ID: 37317923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells
    Yang H; Li H; Lu S; Shan S; Guo Y
    Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.